Author

James Cheng-Chung Wei

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial.

OBJECTIVE We emulated a target trial to compare glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with sodium-glucose cotransporter-2 inhibitors (SGLT2is) regarding hepatic, cardiovascular, and mortality outcomes among liver transplant recipients with diabetes. METHODS Using the TriNetX US Collaborative Network,...

F. Yen, Pei-Lun Liao, Yao-Min Hung et al. · Metabolism: Clinical and Exp... · 0 citations

Open access Aug 2026

Early urate-lowering therapy and cardiometabolic risk in adults without documented major cardiometabolic disease: a real-world cohort study

Background Whether urate-lowering therapy (ULT) affects cardiometabolic outcomes in individuals without established metabolic disease remains uncertain. Materials and methods This retrospective cohort study used TriNetX data (2015–2023) to include adults with newly diagnosed hyperuricemia (UA >7 mg/dL) and no baseline...

An-Ping Huo, Shiow-Ing Wang, Pui-Ying Leong et al. · Frontiers in Endocrinology · 0 citations

Open access Aug 2026

HPV Vaccination and Risk of Head and Neck Cancers: A Large Real-World Cohort Study.

IMPORTANCE Human papillomavirus (HPV) is a primary cause of head and neck cancers (HNC), especially oropharyngeal squamous cell carcinoma (OPSCC). The real-world effectiveness of HPV vaccination in preventing HNC has not been well-defined. OBJECTIVE This study aimed to determine whether HPV vaccination is associated...

Ching-Nung Wu, Wei-Chun Cheng, Sheng-Dean Luo et al. · International Journal of Inf... · 0 citations